Posted by Michael Wonder on 16 Oct 2023
Cheaper medicines for cervical cancer, urotherial cancer and spinal muscular atrophy
16 October 2023 - From 1 October 2023, Australians with cervical cancer, urothelial cancer and spinal muscular atrophy will have access to new or expanded treatment options through the PBS.
Pembrolizumab (Keytruda) will be expanded on the PBS to treat patients with persistent, recurrent, or metastatic cervical cancer.
